Global Continence Inc.
Neuromodulation-based bedwetting device for children with nocturnal enuresis, combining non-invasive transcutaneous nerve stimulation (TENS), remote signaling, and a companion app.
Initial studies report over 80% success within two months; designed to improve treatment outcomes and reduce emotional and financial burden on families.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A